Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001

Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001–2017

Published:2021-02 Issue: Volume:281 Page:547-556
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Seifert Johanna^ORCID,Engel Rolf R.,Bernegger Xueqiong^ORCID,Führmann Fabienne,Bleich Stefan,Stübner Susanne,Sieberer Marcel,Greil Waldemar,Toto Sermin,Grohmann Renate

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference45 articles.

1. Utilization patterns of antidepressants between 1991 and 2011 in a population-based cohort of middle-aged and elderly;Aarts;Eur Psychiatry,2014

2. Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications;Abbing-Karahagopian;Eur J Clin Pharmacol,2014

3. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders;Bridler;Eur Neuropsychopharmacol,2015

4. Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014;Bushnell;JAMA Psychiatry,2017

5. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis;Cipriani;Lancet,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of bipolar depression: clinical practice vs. adherence to guidelines—data from a Bavarian drug surveillance project;Frontiers in Psychiatry;2024-07-02

2. Who is at risk for weight gain after weight‐gain associated treatment with antipsychotics, antidepressants, and mood stabilizers: A machine learning approach;Acta Psychiatrica Scandinavica;2024-04

3. Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study;Psychiatry and Clinical Neurosciences;2023-09-08

4. Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder;Journal of Affective Disorders;2023-07

5. Depression, Angststörungen, bipolare Störung, Schizophrenie, Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung;Arzneiverordnungs-Report 2023;2023